Evidence based management guideline for the COVID-19 pandemic - Review article
- PMID: 32289472
- PMCID: PMC7151371
- DOI: 10.1016/j.ijsu.2020.04.001
Evidence based management guideline for the COVID-19 pandemic - Review article
Abstract
COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 2.5 million people worldwide, resulting in over 170,000 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have been employed to mitigate the spread of disease including careful infection control, the isolation of patients, and social distancing. Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention. Medical therapy involving corticosteroids and antivirals have also been encouraged as part of critical management schemes. However, there is at present no specific antiviral recommended for the treatment of COVID-19, and no vaccine is currently available. Despite the strategic implementation of these measures, the number of new reported cases continues to rise at a profoundly alarming rate. As new findings emerge, there is an urgent need for up-to-date management guidelines. In response to this call, we review what is currently known regarding the management of COVID-19, and offer an evidence-based review of current practice.
Keywords: COVID-19; Management guidelines; Pandemic; SARS-CoV-2.
Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Figures






Comment in
-
Developing guidelines for COVID-19 management: A moving target. An invited commentary on "Evidence based management guideline for the COVID-19 pandemic - Review article".Int J Surg. 2020 Jun;78:42. doi: 10.1016/j.ijsu.2020.04.030. Epub 2020 Apr 21. Int J Surg. 2020. PMID: 32330655 Free PMC article. No abstract available.
-
An invited commentary on: "Evidence based management guideline for the COVID-19 pandemic - Review article".Int J Surg. 2020 Jun;78:154-155. doi: 10.1016/j.ijsu.2020.04.032. Epub 2020 Apr 21. Int J Surg. 2020. PMID: 32330658 Free PMC article. No abstract available.
-
Important considerations regarding the future management of coronavirus (COVID-19).Int J Surg. 2020 Jul;79:6-7. doi: 10.1016/j.ijsu.2020.04.083. Epub 2020 May 5. Int J Surg. 2020. PMID: 32387212 Free PMC article. No abstract available.
-
A COVID-19 pandemic guideline in evidence-based medicine.Evid Based Dent. 2020 Jun;21(2):71-73. doi: 10.1038/s41432-020-0105-7. Evid Based Dent. 2020. PMID: 32591667 Free PMC article.
References
-
- Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2019 https://www.nejm.org/doi/10.1056/NEJMoa2001017 [Internet]. 2020 Jan 24 [cited 2020 Mar 9]; Available from: - DOI - PMC - PubMed
-
- Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. J. Am. Med. Assoc. 2020 Mar http://www.ncbi.nlm.nih.gov/pubmed/32125362 [Internet] Available from: - PMC - PubMed
-
- Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia | NEJM. https://www.nejm.org/doi/full/10.1056/NEJMoa2001316 [Internet]. [cited 2020 Mar 9]. Available from: - DOI - PMC - PubMed
-
- Coronavirus confirmed as pandemic. 2020 Mar 11. https://www.bbc.com/news/world-51839944 BBC News [Internet] [cited 2020 Mar 11]; Available from:
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous